{"meta":{"query_hash":"a6c1e7626157","filters":{"venue":"Cardiology and Therapy"},"cohort_total":19,"direct_labels_cover":0,"predictions_cover":19,"exported":19,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a6c1e7626157","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cardiology+and+Therapy"},"results":[{"id":"W2133616084","doi":"10.1007/s40119-013-0019-y","title":"Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants","year":2013,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Rivaroxaban; Apixaban; Atrial fibrillation; Dabigatran; Warfarin; Stroke (engine); Contraindication; Intensive care medicine; Risk factor; Internal medicine; Cardiology","score_opus":0.0366053928921816,"score_gpt":0.29035098516621954,"score_spread":0.2537455922740379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133616084","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16386573,0.79499316,0.0003426572,0.02282494,0.0012220808,0.000052114392,0.0002428506,0.00001810761,0.016438352],"genre_scores_gemma":[0.5701087,0.4142081,0.0012284277,0.005690122,0.0066300565,0.0000727286,0.00034496904,0.0000071181485,0.0017098202],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997011,0.00008525287,0.000048231028,0.000035404784,0.00009725056,0.000032676817],"domain_scores_gemma":[0.9989004,0.00037675168,0.0003946024,0.000017736265,0.00011530916,0.00019521758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075140625,0.00034306638,0.0010478317,0.00049677835,0.0003194706,0.0008457296,0.00027653703,0.00081444584,0.0019316595],"category_scores_gemma":[0.0028381974,0.00010863389,0.0006082852,0.00062957406,0.00024958162,0.00084925373,0.00029715901,0.0009135968,0.00020310796],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023761443,0.0006795142,0.3325185,0.001715567,0.0011121877,0.0015642678,0.00019011482,0.0005648872,0.0005754883,0.0016246487,0.014929572,0.64214915],"study_design_scores_gemma":[0.0020553279,0.0030969905,0.8824867,0.006106227,0.0030675519,0.012227862,0.00078199035,0.002614437,0.00037318663,0.006395806,0.080678,0.00011583595],"about_ca_topic_score_codex":0.0014098925,"about_ca_topic_score_gemma":0.0035644476,"teacher_disagreement_score":0.0019316595,"about_ca_system_score_codex":0.00033073648,"about_ca_system_score_gemma":0.0006768829,"threshold_uncertainty_score":0.006462097},"labels":[],"label_agreement":null},{"id":"W2270148934","doi":"10.1007/s40119-016-0056-4","title":"Effect of Frailty and Age on Platelet Aggregation and Response to Aspirin in Older Patients with Atrial Fibrillation: A Pilot Study","year":2016,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Atrial fibrillation; Internal medicine; Platelet; Stroke (engine); Platelet activation; Cardiology","score_opus":0.013529569918235559,"score_gpt":0.26932676952783835,"score_spread":0.2557971996096028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2270148934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995695,0.00010847873,0.00003434585,0.000012278524,0.0000035631476,0.00004067898,0.000066997345,0.0000011416648,0.00016316905],"genre_scores_gemma":[0.99946195,0.000069902686,0.00012102752,0.000026181877,0.000016801829,0.0000534284,0.00010039564,6.564482e-7,0.00014981837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994597,0.00021921893,0.00005877391,0.00007958072,0.0000932227,0.00008955953],"domain_scores_gemma":[0.99720275,0.00074215955,0.00072978466,0.00024341868,0.00027115308,0.00081076095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015764545,0.0005216293,0.0005720205,0.00053892995,0.0005212541,0.0004924712,0.00026686993,0.00050506403,0.0022297916],"category_scores_gemma":[0.0030045642,0.00024823577,0.0009468167,0.00052747165,0.00039925534,0.00049936486,0.00063282263,0.0006415836,0.00037504992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01155231,0.003200503,0.97544473,0.00007918549,0.00026710198,0.00019316141,0.00076280953,0.00007239195,0.00090833637,0.000026705751,0.00013247826,0.007360269],"study_design_scores_gemma":[0.00024642047,0.013726357,0.9851929,0.000009383286,0.00008722266,0.00015069343,0.00018772979,0.00012196801,0.000071315175,0.000021708413,0.00017595498,0.000008510303],"about_ca_topic_score_codex":0.0016917943,"about_ca_topic_score_gemma":0.0020194205,"teacher_disagreement_score":0.0022297916,"about_ca_system_score_codex":0.00026276463,"about_ca_system_score_gemma":0.0004999781,"threshold_uncertainty_score":0.0083372},"labels":[],"label_agreement":null},{"id":"W2527804880","doi":"10.1007/s40119-016-0071-5","title":"A Prospective, Randomized, Open-Label Study to Evaluate Two Management Strategies for Gastrointestinal Symptoms in Patients Newly on Treatment with Dabigatran","year":2016,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Boehringer Ingelheim","keywords":"Medicine; Dabigatran; Randomized controlled trial; Gastrointestinal bleeding; Intensive care medicine; Prospective cohort study; Internal medicine; Atrial fibrillation; Warfarin","score_opus":0.05798855733968124,"score_gpt":0.3663753129274868,"score_spread":0.3083867555878056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527804880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921767,0.0013209399,0.00038819545,0.0004378156,0.00032970295,0.0036776203,0.00064709753,0.000030330688,0.0009914988],"genre_scores_gemma":[0.9883774,0.00096561085,0.0015312748,0.0011774665,0.0006329817,0.005115764,0.00101037,0.000008789613,0.0011803086],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977964,0.0012649712,0.00017304416,0.00039699834,0.00013886335,0.0002297856],"domain_scores_gemma":[0.9958133,0.0012092728,0.0010762374,0.00035350866,0.00024229514,0.001305423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038167415,0.001795462,0.0027830708,0.00037444205,0.0006503682,0.00132825,0.0009719062,0.002168866,0.006953795],"category_scores_gemma":[0.003936086,0.0009879633,0.0022781694,0.00045629108,0.001837583,0.0014410664,0.00055687124,0.003124899,0.0010979322],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9773728,0.014339339,0.0027161413,0.00015362276,0.000621268,0.000025874517,0.0000320831,0.00008834425,0.0007429473,0.000052509324,0.00026641347,0.0035885922],"study_design_scores_gemma":[0.9121914,0.08404217,0.002861614,0.000011746375,0.00031224705,0.000021764065,0.000016113727,0.00018959642,0.00010692795,0.00005682091,0.00018061162,0.000009071634],"about_ca_topic_score_codex":0.0009464338,"about_ca_topic_score_gemma":0.0019705447,"teacher_disagreement_score":0.006953795,"about_ca_system_score_codex":0.00087448355,"about_ca_system_score_gemma":0.0020171115,"threshold_uncertainty_score":0.023262799},"labels":[],"label_agreement":null},{"id":"W2737671506","doi":"10.1007/s40119-017-0094-6","title":"Management and Prevention of Saphenous Vein Graft Failure: A Review","year":2017,"lang":"en","type":"review","venue":"Cardiology and Therapy","topic":"Cardiac and Coronary Surgery Techniques","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Revascularization; Saphenous vein graft; Coronary artery disease; Cardiology; Internal medicine; Internal thoracic artery; Artery; Vein; Bypass grafting; Percutaneous; Percutaneous coronary intervention; Surgery; Medical therapy; Myocardial infarction","score_opus":0.06446204936183224,"score_gpt":0.37131431108049534,"score_spread":0.3068522617186631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737671506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000878694,0.99930394,0.000043354798,0.00015495271,0.00008054173,0.0000034808447,0.000012704915,0.000002663928,0.00031049992],"genre_scores_gemma":[0.00044941696,0.9992009,0.0001046678,0.00007772482,0.000081188824,0.0000033527667,0.000015497522,5.8702733e-7,0.0000667806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971896,0.000056478668,0.000078545185,0.00004637756,0.00008371122,0.000015923752],"domain_scores_gemma":[0.99925786,0.0004683784,0.00011163014,0.000012646934,0.00012260943,0.000026879397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059279695,0.00071481644,0.001212526,0.00276202,0.00028132938,0.0008669837,0.0009740262,0.0008332089,0.0037159561],"category_scores_gemma":[0.0017907686,0.0001951822,0.00077438715,0.0019922224,0.0003330053,0.00094743713,0.00045539578,0.0010760531,0.0008603582],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056971134,0.00009262385,0.00039679406,0.054758508,0.00022995437,0.00020558124,0.0000843468,0.00029981838,0.0003201227,0.001476263,0.017628144,0.9244508],"study_design_scores_gemma":[0.000042952746,0.00025222613,0.0031939351,0.07569888,0.0011587982,0.0043014176,0.00021018686,0.00021005921,0.00037280287,0.0026127647,0.9119012,0.000044836415],"about_ca_topic_score_codex":0.0012153995,"about_ca_topic_score_gemma":0.0018444055,"teacher_disagreement_score":0.0037159561,"about_ca_system_score_codex":0.00037200237,"about_ca_system_score_gemma":0.0011276454,"threshold_uncertainty_score":0.012431145},"labels":[],"label_agreement":null},{"id":"W2804977753","doi":"10.1007/s40119-018-0110-5","title":"Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris","year":2018,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trimetazidine; Medicine; Adverse effect; Regimen; Randomized controlled trial; Stable angina; Internal medicine; Angina; Anesthesia; Coronary artery disease; Myocardial infarction","score_opus":0.06926098704122748,"score_gpt":0.3636599594483907,"score_spread":0.29439897240716323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804977753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966363,0.0022934698,0.0001298337,0.000100918645,0.000057764213,0.00022605447,0.000051106465,0.000010804643,0.0004937811],"genre_scores_gemma":[0.9982352,0.0007431327,0.00028201457,0.00013335256,0.00011870263,0.0001627953,0.000073073956,0.0000023851576,0.0002491862],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994727,0.00030131184,0.000054103544,0.00006726748,0.00006324971,0.00004145119],"domain_scores_gemma":[0.99898046,0.00034515423,0.00029133388,0.000048082773,0.000058012392,0.00027697685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014195424,0.00038069842,0.0011792184,0.0002042713,0.0002021622,0.00045489357,0.00033192543,0.0005961961,0.0022864987],"category_scores_gemma":[0.0017981438,0.00020695201,0.0005580867,0.00016703921,0.00043395613,0.00034747514,0.00019160479,0.0007856042,0.0003035806],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84768444,0.011768011,0.010674049,0.0006558463,0.00047847346,0.0001482,0.00014677405,0.00031016124,0.030788219,0.00010656869,0.0003811185,0.0968582],"study_design_scores_gemma":[0.1892217,0.7610353,0.043190196,0.00006666447,0.0005921595,0.00022637153,0.000085590786,0.0007789121,0.0037514844,0.00008214497,0.0009430635,0.000026445368],"about_ca_topic_score_codex":0.00015245838,"about_ca_topic_score_gemma":0.00032741224,"teacher_disagreement_score":0.0022864987,"about_ca_system_score_codex":0.00025039914,"about_ca_system_score_gemma":0.0003735171,"threshold_uncertainty_score":0.007649064},"labels":[],"label_agreement":null},{"id":"W2917360774","doi":"10.1007/s40119-019-0128-3","title":"Effectiveness of Long-acting Trimetazidine in Different Clinical Situations in Patients with Stable Angina Pectoris: Findings from ODA Trial","year":2019,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Servier","keywords":"Medicine; Tolerability; Trimetazidine; Angina; Internal medicine; Observational study; Canadian Cardiovascular Society; Randomized controlled trial; Cardiology; Adverse effect; Myocardial infarction","score_opus":0.024319566678029966,"score_gpt":0.31295013783528536,"score_spread":0.2886305711572554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917360774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974267,0.0016909331,0.000038396975,0.000096545176,0.000023027786,0.00012189274,0.00025491076,0.0000046156083,0.00034286635],"genre_scores_gemma":[0.9978132,0.00071249984,0.00016667855,0.00017707545,0.00009168164,0.00014675941,0.00068328064,0.0000021407031,0.00020656739],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99910045,0.00045207446,0.000096329706,0.00014823367,0.000107446125,0.00009550935],"domain_scores_gemma":[0.997988,0.0004526211,0.0007446781,0.0001542358,0.00010802569,0.0005524844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00235825,0.0005551166,0.0013709364,0.00019298303,0.00034345925,0.00089749414,0.00045222984,0.0006910692,0.0013492267],"category_scores_gemma":[0.0021238462,0.000254872,0.0015149724,0.00035937395,0.00039869035,0.00047224364,0.00037490515,0.0012412133,0.00018043649],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77347475,0.008710474,0.17114511,0.00073544757,0.006633025,0.00014877043,0.00029117227,0.00034028437,0.005227715,0.00006384821,0.0008441639,0.032385264],"study_design_scores_gemma":[0.33444762,0.10772698,0.5482956,0.000111315734,0.006006417,0.00028742882,0.00021738317,0.0007425095,0.0008926146,0.0000962205,0.0011239817,0.000051844385],"about_ca_topic_score_codex":0.000823039,"about_ca_topic_score_gemma":0.001982064,"teacher_disagreement_score":0.00235825,"about_ca_system_score_codex":0.0004116899,"about_ca_system_score_gemma":0.0005181434,"threshold_uncertainty_score":0.0124717355},"labels":[],"label_agreement":null},{"id":"W2968142039","doi":"10.1007/s40119-019-00145-7","title":"Effectiveness and Impact on Adherence of a New Fixed-Dose Combination of Ivabradine and Metoprolol in a Wide Range of Stable Angina Patients in Real-Life Practice","year":2019,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Servier","keywords":"Medicine; Ivabradine; Tolerability; Metoprolol; Angina; Internal medicine; Cardiology; Myocardial infarction; Canadian Cardiovascular Society; Coronary artery disease; Heart rate; Adverse effect; Blood pressure","score_opus":0.017177069438999007,"score_gpt":0.3181083266908605,"score_spread":0.3009312572518615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968142039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989256,0.0006350038,0.000047312333,0.00006377698,0.000005218947,0.000018529525,0.00006772985,0.000002912415,0.00023385337],"genre_scores_gemma":[0.9994647,0.0002001547,0.00013961089,0.000047136225,0.0000129095515,0.000015397945,0.00008331938,5.151676e-7,0.000036372192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791795,0.0009794561,0.00025127566,0.00025535462,0.00047010463,0.00012590177],"domain_scores_gemma":[0.996068,0.000909088,0.002027088,0.00018426377,0.00021935436,0.00059212657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021948414,0.00021408667,0.0005977334,0.00042909064,0.00030407362,0.00050029677,0.00028355498,0.00057529233,0.00064979045],"category_scores_gemma":[0.006242537,0.00014759113,0.00061522203,0.00050296343,0.00019859866,0.00031484713,0.00025561985,0.00049271324,0.00009394967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062630097,0.0025021788,0.9469919,0.000152022,0.00068916834,0.00008312358,0.00022054299,0.00031674438,0.0006347624,0.000017929977,0.00016515827,0.0419634],"study_design_scores_gemma":[0.0005500654,0.011559236,0.9860999,0.000043515956,0.00022979669,0.00018539974,0.00013441315,0.0008426373,0.00011045372,0.000028092905,0.00020566513,0.000010761982],"about_ca_topic_score_codex":0.0019538808,"about_ca_topic_score_gemma":0.00228904,"teacher_disagreement_score":0.0021948414,"about_ca_system_score_codex":0.00038605553,"about_ca_system_score_gemma":0.00039357127,"threshold_uncertainty_score":0.011607528},"labels":[],"label_agreement":null},{"id":"W3026117329","doi":"10.1007/s40119-020-00174-7","title":"Effectiveness of Trimetazidine in Patients with Stable Angina Pectoris of Various Durations: Results from ODA","year":2020,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Servier","keywords":"Trimetazidine; Medicine; Stable angina; Angina; Cardiology; Internal medicine; Coronary artery disease; Myocardial infarction","score_opus":0.01200293812737145,"score_gpt":0.22891049285965775,"score_spread":0.21690755473228632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026117329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989139,0.00077985047,0.000022214208,0.000015091988,0.0000037531725,0.000020591879,0.000086530104,0.0000018435685,0.00015617885],"genre_scores_gemma":[0.9993487,0.0002567571,0.00006107415,0.000028825049,0.000012033992,0.00001709074,0.00020428006,7.5202126e-7,0.000070475275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996469,0.00013934236,0.00004377983,0.000067995454,0.000059019276,0.00004301104],"domain_scores_gemma":[0.999114,0.00021184265,0.00032618488,0.00005716379,0.00008554124,0.00020521373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010169632,0.00026800612,0.0007018446,0.00025952517,0.00022496501,0.0003177259,0.00017978063,0.00026361857,0.0006511429],"category_scores_gemma":[0.0011127827,0.00012232683,0.0009055734,0.00030242334,0.0001532533,0.00018055456,0.00024330849,0.00034357244,0.000106938234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12914075,0.007822601,0.7688841,0.0006229448,0.001761658,0.00017496054,0.00048152392,0.0004061996,0.008084695,0.00002887525,0.0002583977,0.08233333],"study_design_scores_gemma":[0.0048735184,0.03486308,0.95797634,0.000026709515,0.00072043075,0.00014877593,0.00011888145,0.00029483496,0.0005657857,0.000013194482,0.00038663327,0.0000117895515],"about_ca_topic_score_codex":0.0012505535,"about_ca_topic_score_gemma":0.0015802167,"teacher_disagreement_score":0.0012505535,"about_ca_system_score_codex":0.00035933475,"about_ca_system_score_gemma":0.0003649296,"threshold_uncertainty_score":0.0053782463},"labels":[],"label_agreement":null},{"id":"W3107892918","doi":"10.1007/s40119-020-00202-6","title":"Trimetazidine and Bisoprolol to Treat Angina in Symptomatic Patients: Post Hoc Analysis From the CHOICE-2 Study","year":2020,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Servier","keywords":"Medicine; Bisoprolol; Trimetazidine; Angina; Internal medicine; Cardiology; Post-hoc analysis; Anesthesia; Heart failure; Myocardial infarction","score_opus":0.02200588959214892,"score_gpt":0.28335997060801793,"score_spread":0.261354081015869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107892918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882466,0.00039950272,0.00011162261,0.000033491033,0.000033319735,0.00007236568,0.00032967137,0.000005426494,0.00018997428],"genre_scores_gemma":[0.9984086,0.00009710363,0.00016691835,0.00006494048,0.00007344642,0.0001615389,0.0007585845,0.0000069618527,0.00026198436],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.996861,0.0020331002,0.0001702851,0.00044138022,0.0002849686,0.00020926059],"domain_scores_gemma":[0.9931243,0.0044483976,0.000984908,0.0005120599,0.0003025545,0.0006278288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055807694,0.00093832304,0.0024332555,0.00035246566,0.00026809456,0.0007383125,0.0007132534,0.00068344997,0.0028588534],"category_scores_gemma":[0.004935954,0.00036977307,0.0033070445,0.0003714511,0.00048364018,0.0007312622,0.00058403396,0.0010217455,0.00020832299],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77858377,0.0015901988,0.19991899,0.000376527,0.0100660175,0.00026284077,0.00017197627,0.000730138,0.0029092352,0.00008888609,0.0008702792,0.0044311574],"study_design_scores_gemma":[0.0890907,0.11860812,0.7677263,0.000060812872,0.013550966,0.000374899,0.0003231593,0.0065264096,0.0020125862,0.00019369392,0.0014344599,0.000097869815],"about_ca_topic_score_codex":0.00050565944,"about_ca_topic_score_gemma":0.00084083405,"teacher_disagreement_score":0.0055807694,"about_ca_system_score_codex":0.00035488437,"about_ca_system_score_gemma":0.0005103482,"threshold_uncertainty_score":0.029514253},"labels":[],"label_agreement":null},{"id":"W4280490176","doi":"10.1007/s40119-022-00265-7","title":"Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)","year":2022,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Colorado Denver; School of Medicine, Vanderbilt University; School of Medicine, Stanford University; Samsung; Aarhus Universitetshospital; University of Alberta; University of Utah; Universitair Medisch Centrum Groningen; Pfizer; Northwestern University; Sungkyunkwan University; Vanderbilt University; Yale University; Aarhus Universitet","keywords":"Transthyretin; Amyloidosis; Medicine; Internal medicine","score_opus":0.02476310667573326,"score_gpt":0.26778167958781246,"score_spread":0.2430185729120792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280490176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974195,0.00021353798,0.000046246892,0.00004384681,0.000006305381,0.000005438222,0.0019413478,0.000002428693,0.0003213448],"genre_scores_gemma":[0.99842656,0.0000875831,0.00002484858,0.000024113648,0.000008260176,0.000009922577,0.0013249726,0.000001981788,0.00009185802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999514,0.0001229063,0.00005884452,0.00011847038,0.00010502813,0.00008077283],"domain_scores_gemma":[0.9987533,0.00017660145,0.0005981259,0.00007204528,0.0001579435,0.00024186878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008516759,0.00021251845,0.00034706545,0.0007010334,0.00021201126,0.00039018554,0.00023009478,0.00027440497,0.0010450513],"category_scores_gemma":[0.0017324565,0.00015607371,0.00061217847,0.0010072072,0.00013323985,0.0003573973,0.00043045287,0.0003561497,0.00018746323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007172166,0.0000071349477,0.9993949,0.000003547655,0.000036496127,0.000018912755,0.000023726252,0.000010985518,0.00003386263,0.0000066630028,0.00008487595,0.00030718534],"study_design_scores_gemma":[0.0000055620185,0.00003882024,0.9996032,0.000003264523,0.00001646115,0.00007000277,0.00008014834,0.00006114648,0.000012082187,0.000009533408,0.000098255456,0.0000014216045],"about_ca_topic_score_codex":0.004707872,"about_ca_topic_score_gemma":0.004925994,"teacher_disagreement_score":0.004707872,"about_ca_system_score_codex":0.00018662786,"about_ca_system_score_gemma":0.000259493,"threshold_uncertainty_score":0.009360969},"labels":[],"label_agreement":null},{"id":"W4311500443","doi":"10.1007/s40119-022-00289-z","title":"Hyperkalemia: Prevalence, Predictors and Emerging Treatments","year":2022,"lang":"en","type":"review","venue":"Cardiology and Therapy","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Horizon Health Network; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Hyperkalemia; Medicine; Kidney disease; Intensive care medicine; Epidemiology; Disease; Adverse effect; Diabetes mellitus; Heart failure; Internal medicine; Endocrinology","score_opus":0.03820853109615856,"score_gpt":0.3212420952053226,"score_spread":0.283033564109164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311500443","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023831894,0.9988212,0.000060506783,0.000345207,0.000075835276,0.0000029709206,0.000045597233,0.000004272854,0.00040602463],"genre_scores_gemma":[0.0016531602,0.99781656,0.00012621583,0.00013349966,0.00010237863,0.000004608592,0.00005758024,0.0000012669689,0.00010464927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962425,0.000073444666,0.000105145045,0.00007391165,0.00009290643,0.000030329431],"domain_scores_gemma":[0.9992865,0.0004042047,0.00012809267,0.0000124386725,0.00013678893,0.000032087974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070647866,0.00054711336,0.0012828998,0.0025402796,0.00021627519,0.0011877024,0.00067965925,0.00070422975,0.0031332],"category_scores_gemma":[0.002051292,0.00021011656,0.0009419041,0.0022889378,0.00036925366,0.00095017895,0.00053200254,0.0011163768,0.0007942943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026256792,0.000080988946,0.002493382,0.05257025,0.0004823508,0.0003153349,0.00013727596,0.0003936099,0.0006254648,0.0026824642,0.021391414,0.918565],"study_design_scores_gemma":[0.000106624284,0.00033831008,0.018666385,0.077365205,0.0021565428,0.008320797,0.0004834369,0.00055589544,0.0007464756,0.0070903953,0.884073,0.00009694022],"about_ca_topic_score_codex":0.0018716396,"about_ca_topic_score_gemma":0.0027487262,"teacher_disagreement_score":0.0031332,"about_ca_system_score_codex":0.00066287303,"about_ca_system_score_gemma":0.0016716621,"threshold_uncertainty_score":0.010481596},"labels":[],"label_agreement":null},{"id":"W4317423838","doi":"10.1007/s40119-022-00300-7","title":"Guideline LDL-C Threshold Achievement in Acute Myocardial Infarction Patients: A Real-World Evidence Study Demonstrating the Impact of Treatment Intensification with PCSK9i","year":2023,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary; Amgen (Canada)","funders":"Amgen Canada; Government of Alberta; Alberta Precision Laboratories; Amgen","keywords":"Ezetimibe; Medicine; Statin; Internal medicine; Myocardial infarction; Cohort; Retrospective cohort study; Evolocumab; Guideline; Cardiology; Cholesterol; Lipoprotein; Pathology","score_opus":0.04897385325442376,"score_gpt":0.3544296291000235,"score_spread":0.30545577584559974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317423838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7455646,0.231678,0.00036973835,0.0049554594,0.00023359062,0.0004583542,0.008128336,0.000026659829,0.008585266],"genre_scores_gemma":[0.9770552,0.018951647,0.00046386704,0.00074487925,0.00012852543,0.00006893597,0.0024651634,0.000003164858,0.000118638396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941048,0.0017046324,0.0008116768,0.0005786118,0.002503512,0.00029680406],"domain_scores_gemma":[0.974773,0.0066851806,0.010877805,0.00065051974,0.005665888,0.0013476127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006091765,0.00030554814,0.0011977723,0.0008324915,0.00042104293,0.0018390162,0.0009865477,0.0006516851,0.0011546368],"category_scores_gemma":[0.022498438,0.000257593,0.0013762212,0.0035526354,0.00052302907,0.00039661926,0.00045602498,0.0009447392,0.00008847107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014382599,0.00045934442,0.82405984,0.010606909,0.01839434,0.0001398768,0.00034797145,0.00091493584,0.00039201783,0.00055205636,0.00723208,0.122518],"study_design_scores_gemma":[0.0024772056,0.0009120082,0.97651345,0.0025190194,0.012204577,0.00012080764,0.00020975577,0.0004913273,0.000099481455,0.00013711902,0.0042764903,0.000038793554],"about_ca_topic_score_codex":0.26266253,"about_ca_topic_score_gemma":0.4245089,"teacher_disagreement_score":0.26266253,"about_ca_system_score_codex":0.0073410673,"about_ca_system_score_gemma":0.011328308,"threshold_uncertainty_score":0.52226734},"labels":[],"label_agreement":null},{"id":"W4324304841","doi":"10.1007/s40119-023-00310-z","title":"Correction to: Guideline LDL-C Threshold Achievement in Acute Myocardial Infarction Patients: A Real-World Evidence Study Demonstrating the Impact of Treatment Intensification with PCSK9i","year":2023,"lang":"en","type":"erratum","venue":"Cardiology and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary; Amgen (Canada)","funders":"","keywords":"Medicine; Guideline; Myocardial infarction; Intensive care medicine; Internal medicine; Cardiology; Pathology","score_opus":0.04057259202886799,"score_gpt":0.3490907356350811,"score_spread":0.3085181436062131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324304841","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054789583,0.0010413178,0.00024334315,0.0679795,0.92745745,0.000045177556,0.001940769,0.00011128404,0.0011262887],"genre_scores_gemma":[0.006436036,0.008768679,0.004995251,0.2599691,0.63435864,0.0006722636,0.003643414,0.0009771119,0.08017946],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909841,0.002212338,0.002222198,0.0010419156,0.0028583838,0.0006811017],"domain_scores_gemma":[0.9312886,0.022481423,0.005024209,0.0030506386,0.034671303,0.0034837928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009191601,0.0028766666,0.0040986715,0.004810376,0.002431992,0.006043568,0.0038839155,0.009925144,0.056008153],"category_scores_gemma":[0.1249172,0.0017698448,0.0034709412,0.0039537787,0.002287544,0.0022928482,0.0018675793,0.018893426,0.0272026],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040634437,0.0000049987816,0.00006219212,0.00018866849,0.000020202537,0.00005220711,0.000009036357,0.000021245904,0.000007761196,0.00016515529,0.9972844,0.0021434838],"study_design_scores_gemma":[0.00061709835,0.000041892232,0.0020154454,0.0024602641,0.0002447369,0.0004063501,0.00012870802,0.00036262607,0.00022037886,0.0016262198,0.9917883,0.00008796088],"about_ca_topic_score_codex":0.029642971,"about_ca_topic_score_gemma":0.04472894,"teacher_disagreement_score":0.056008153,"about_ca_system_score_codex":0.005937719,"about_ca_system_score_gemma":0.011438379,"threshold_uncertainty_score":0.18736595},"labels":[],"label_agreement":null},{"id":"W4387429392","doi":"10.1007/s40119-023-00334-5","title":"Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study","year":2023,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Université Laval; Centre hospitalier universitaire de Québec; Amgen (Canada)","funders":"Amgen Canada; Amgen","keywords":"Evolocumab; Medicine; Hyperlipidemia; Internal medicine; Diabetes mellitus; Endocrinology; Total cholesterol; Cholesterol","score_opus":0.017380496165767822,"score_gpt":0.2911795570283895,"score_spread":0.2737990608626217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387429392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450964,0.0017795942,0.000067827925,0.0001403334,0.0000056025747,0.00001448895,0.0029462408,0.0000032125422,0.0005331347],"genre_scores_gemma":[0.997547,0.0004500075,0.00007578868,0.000054146218,0.0000085110505,0.000012650348,0.0018065048,0.0000021976261,0.000043190543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983606,0.0005589599,0.00027856947,0.00030460948,0.00027203027,0.00022517244],"domain_scores_gemma":[0.9937627,0.0009003804,0.004203375,0.00031609426,0.0003896909,0.00042788155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021813815,0.00026612624,0.0005661481,0.0014620557,0.00037265403,0.0012372832,0.00037141802,0.00030143172,0.0012745241],"category_scores_gemma":[0.0046244385,0.00018989133,0.00081071677,0.003553179,0.0004182128,0.0004847994,0.00076179864,0.0004208363,0.00015306317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012022141,0.0000067201167,0.99837166,0.000036069414,0.00015586616,0.00002593638,0.00008625694,0.00003519367,0.000022601194,0.000021811376,0.00014304025,0.0009746018],"study_design_scores_gemma":[0.00001759544,0.000032438482,0.9987662,0.000043637763,0.000103080245,0.000118446,0.0003427249,0.000085002735,0.00002082986,0.000014672041,0.00045017138,0.0000051756647],"about_ca_topic_score_codex":0.01848898,"about_ca_topic_score_gemma":0.017486423,"teacher_disagreement_score":0.01848898,"about_ca_system_score_codex":0.0007372529,"about_ca_system_score_gemma":0.00080049154,"threshold_uncertainty_score":0.036762714},"labels":[],"label_agreement":null},{"id":"W4391324086","doi":"10.1007/s40119-024-00349-6","title":"Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study","year":2024,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital; Amgen (Canada)","funders":"Amgen Canada; Alberta Precision Laboratories; Government of Alberta","keywords":"Medicine; Internal medicine; Myocardial infarction; Ezetimibe; Unstable angina; Cardiology; Statin; Population; Stroke (engine); Guideline; Acute coronary syndrome; Coronary artery disease; Diabetes mellitus; Endocrinology","score_opus":0.03969821616150351,"score_gpt":0.29880981830710146,"score_spread":0.2591116021455979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391324086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974903,0.00036162892,0.0001384446,0.00003299515,0.00000686184,0.000050107516,0.0016504208,0.000004201541,0.00026509177],"genre_scores_gemma":[0.9970413,0.00017458844,0.00019068219,0.000078374185,0.00001788766,0.00005940469,0.0023498472,0.0000031840234,0.000084774154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997769,0.00049567997,0.00033635733,0.0006195149,0.00049456843,0.0002848919],"domain_scores_gemma":[0.9942631,0.000693495,0.00256833,0.0007756783,0.0009790588,0.00072035944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017990146,0.00058754155,0.0008374318,0.0012721338,0.0010999563,0.0015559219,0.0012546518,0.0009162076,0.00090709585],"category_scores_gemma":[0.004352855,0.00082255685,0.0010024972,0.003880801,0.00094413233,0.0007320341,0.00090989174,0.0010399098,0.00028640783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015717282,0.00004172095,0.9991353,0.0000153602,0.00014878894,0.000047174697,0.00008415406,0.00003242597,0.000040651423,0.000011206308,0.00009043649,0.0001956135],"study_design_scores_gemma":[0.000041640254,0.00013920134,0.99870276,0.000014373028,0.00013209289,0.00021229028,0.00027750045,0.00020926508,0.000023289489,0.000016120395,0.00021958939,0.000011867506],"about_ca_topic_score_codex":0.14713901,"about_ca_topic_score_gemma":0.12861948,"teacher_disagreement_score":0.14713901,"about_ca_system_score_codex":0.0024222857,"about_ca_system_score_gemma":0.002557806,"threshold_uncertainty_score":0.2925651},"labels":[],"label_agreement":null},{"id":"W4408608338","doi":"10.1007/s40119-025-00402-y","title":"Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care","year":2025,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"AstraZeneca","keywords":"Medicine; Amyloidosis; AL amyloidosis; Intensive care medicine; Internal medicine; Immunology","score_opus":0.039926299408125615,"score_gpt":0.35001889310870066,"score_spread":0.31009259370057507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408608338","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059938226,0.0023226072,0.013839075,0.015889557,0.0015479102,0.94691604,0.0053679445,0.00012941398,0.007993605],"genre_scores_gemma":[0.015140665,0.00089850806,0.047258403,0.008005151,0.00038982037,0.9257529,0.00084245217,0.000025249605,0.0016867572],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8983972,0.07475347,0.009298876,0.0069041518,0.008117379,0.0025289776],"domain_scores_gemma":[0.8666458,0.06128284,0.019567467,0.008893802,0.026162537,0.017447546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14707673,0.001644985,0.0024089187,0.0036856006,0.0023799865,0.0071717463,0.0040718233,0.0056012995,0.035344433],"category_scores_gemma":[0.1645362,0.0015522977,0.002898186,0.0032780985,0.0041356804,0.0044476283,0.005051268,0.0069233174,0.006358923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.085664146,0.010790966,0.03537523,0.12249523,0.0055462304,0.0017347464,0.009380772,0.0055921827,0.0030559083,0.1325132,0.1860999,0.40175158],"study_design_scores_gemma":[0.11570854,0.015830409,0.030370392,0.13297303,0.0064616464,0.0008987232,0.0059176176,0.009131377,0.00456056,0.08273242,0.5949139,0.0005013712],"about_ca_topic_score_codex":0.0009736833,"about_ca_topic_score_gemma":0.003045018,"teacher_disagreement_score":0.14707673,"about_ca_system_score_codex":0.0065308753,"about_ca_system_score_gemma":0.04551877,"threshold_uncertainty_score":0.77782536},"labels":[],"label_agreement":null},{"id":"W4409924070","doi":"10.1007/s40119-025-00405-9","title":"Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study","year":2025,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Trimetazidine; Observational study; Internal medicine; Acute coronary syndrome; Cardiology; Adverse effect; Myocardial infarction","score_opus":0.017952775489749093,"score_gpt":0.279311719400205,"score_spread":0.2613589439104559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409924070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987417,0.0006727832,0.000030746436,0.00005254627,0.0000034234683,0.000044161385,0.0002491667,0.0000019733372,0.00020348711],"genre_scores_gemma":[0.9991621,0.0002943926,0.00010546209,0.00007075314,0.00000853281,0.000029380852,0.00027867669,9.184883e-7,0.000049763352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933857,0.00029447913,0.00007594044,0.00010385015,0.00011149467,0.0000757489],"domain_scores_gemma":[0.9979315,0.00031240378,0.0011384898,0.00011951535,0.00018281951,0.0003153053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011067162,0.0002840748,0.00071983546,0.00033471515,0.00028083439,0.0004451524,0.00027633252,0.0005034502,0.0005497131],"category_scores_gemma":[0.0024201204,0.00027260493,0.001049748,0.00041669427,0.00029554317,0.0002586934,0.0003389812,0.00037496144,0.000098920405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004043572,0.0008930344,0.9859557,0.00024748486,0.00061357574,0.000115988856,0.00028875915,0.00008722312,0.0013100425,0.000023128714,0.00018310416,0.0062384172],"study_design_scores_gemma":[0.00070008886,0.004082603,0.993789,0.00006191206,0.00037407535,0.0001454371,0.00019768506,0.00017138736,0.00012756803,0.000015562573,0.00032360654,0.000010888285],"about_ca_topic_score_codex":0.0078468,"about_ca_topic_score_gemma":0.013450262,"teacher_disagreement_score":0.0078468,"about_ca_system_score_codex":0.00051431276,"about_ca_system_score_gemma":0.0005763664,"threshold_uncertainty_score":0.015602231},"labels":[],"label_agreement":null},{"id":"W4410634442","doi":"10.1007/s40119-025-00417-5","title":"Correction: Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care","year":2025,"lang":"en","type":"erratum","venue":"Cardiology and Therapy","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Amyloidosis; Medicine; Intensive care medicine; Pathology","score_opus":0.037341238063662574,"score_gpt":0.33834865369191747,"score_spread":0.3010074156282549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410634442","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009153779,0.0011518678,0.0007786335,0.17314513,0.8207533,0.00029689886,0.0015083678,0.00016145757,0.0021127881],"genre_scores_gemma":[0.004589155,0.0042449464,0.009804625,0.38861623,0.52929676,0.002884249,0.00087164756,0.0007940582,0.058898386],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9765133,0.008960143,0.0044722613,0.0022281492,0.006239923,0.0015862068],"domain_scores_gemma":[0.8074908,0.10038448,0.012539444,0.005740431,0.065300144,0.008544603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027793586,0.0026665132,0.003932948,0.004597441,0.0035597782,0.007676659,0.0043232962,0.01597637,0.057831977],"category_scores_gemma":[0.3165847,0.0018961681,0.0029626682,0.00308168,0.004498209,0.002657679,0.0029849098,0.029895259,0.024015144],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000675819,0.0000068861923,0.00005914679,0.0003560968,0.00002898175,0.000082282124,0.00003102067,0.000032270393,0.00002009348,0.0007634229,0.995765,0.002787334],"study_design_scores_gemma":[0.0006704316,0.000043385604,0.0008962523,0.0035447804,0.0002308315,0.000371098,0.00014793461,0.00045024473,0.00022983096,0.0052285143,0.9881147,0.00007196718],"about_ca_topic_score_codex":0.008197487,"about_ca_topic_score_gemma":0.015499238,"teacher_disagreement_score":0.057831977,"about_ca_system_score_codex":0.0074229357,"about_ca_system_score_gemma":0.015253112,"threshold_uncertainty_score":0.1934672},"labels":[],"label_agreement":null},{"id":"W4412156652","doi":"10.1007/s40119-025-00421-9","title":"Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOS","year":2025,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"VA Greater Los Angeles Healthcare System; School of Medicine, Vanderbilt University; RWTH Aachen University; National Taiwan University; Universitair Medisch Centrum Groningen; National Institute of Diabetes and Digestive and Kidney Diseases; National Taiwan University Hospital; Universiti Malaya; University of Alberta; King Faisal Specialist Hospital and Research Centre; University of Colorado Denver; Universität Heidelberg; Pfizer; Medical Center, University of Pittsburgh; Samsung; Centre Hospitalier Universitaire de Toulouse; University of Pittsburgh; Cleveland Clinic; Sungkyunkwan University; Yale University; Vanderbilt University","keywords":"Medicine; Transthyretin; Internal medicine; Cohort; Amyloidosis; Population; Cohort study; Incidence (geometry); Environmental health","score_opus":0.009742529089259655,"score_gpt":0.24867907800684047,"score_spread":0.23893654891758082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412156652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939823,0.00008786203,0.000029594345,0.0000212158,0.0000031188847,0.000005712704,0.00034960697,0.000001322956,0.00010333668],"genre_scores_gemma":[0.9987783,0.000073780175,0.000032661635,0.000030239502,0.000012889703,0.000012451628,0.0010119101,0.0000020078955,0.00004589774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999419,0.00012797641,0.00005919734,0.0001988575,0.00009234038,0.00010270385],"domain_scores_gemma":[0.99850595,0.00023435579,0.00060415483,0.00015467843,0.00015815698,0.0003426619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008876015,0.00033005988,0.00060160167,0.00077761087,0.00056703674,0.00088093855,0.00041471224,0.0005371289,0.0010331194],"category_scores_gemma":[0.0015935503,0.0002729659,0.0008349785,0.001041691,0.0003812808,0.0006664901,0.00082330575,0.0007618716,0.00024353522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005701069,0.000052449406,0.9981382,0.00000814674,0.000110817266,0.0000907521,0.000094332616,0.000053519285,0.00014444062,0.000014863839,0.00013379038,0.00058860553],"study_design_scores_gemma":[0.00007609647,0.000417014,0.99779034,0.000008786865,0.00009970339,0.00047407325,0.00041912575,0.0003867189,0.00004500516,0.000030761938,0.00024290262,0.0000094916195],"about_ca_topic_score_codex":0.0043521817,"about_ca_topic_score_gemma":0.004252929,"teacher_disagreement_score":0.0043521817,"about_ca_system_score_codex":0.00048804597,"about_ca_system_score_gemma":0.0004587712,"threshold_uncertainty_score":0.0086537},"labels":[],"label_agreement":null}]}